| Tag | Content |
|---|
EnhancerAtlas ID | HS175-04972 |
Organism | Homo sapiens |
Tissue/cell | SK-N-MC |
Coordinate | chr11:93274280-93276300 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CEBPA | MA0102.3 | chr11:93274654-93274665 | TATTATGCAAT | - | 6.02 | | FOSL1 | MA0477.1 | chr11:93275132-93275143 | AGTGACTCATC | + | 6.02 | | GATA2 | MA0036.3 | chr11:93275100-93275111 | ACAGATAAGAA | - | 6.14 | | Gata1 | MA0035.3 | chr11:93275100-93275111 | ACAGATAAGAA | - | 6.62 | | JUND | MA0491.1 | chr11:93275132-93275143 | AGTGACTCATC | + | 6.32 | | Nr5a2 | MA0505.1 | chr11:93274362-93274377 | AATGTCAAGGCCAGC | + | 6.32 | | Zfx | MA0146.2 | chr11:93276273-93276287 | GGCGCCCAGGCCTG | + | 6.77 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_09940 | chr11:93269645-93277387 | CD14 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr11 | 93274800 | 93275200 | | chr11 | 93275200 | 93275600 |
|
Enhancer Sequence | TCCAGCACCA TGGCTTGATC ATTAATGTGT GGTGTGACCC TGGCCAAGTC ACTTCAATGC 60
TGTGATGGCC CTCAGCACCC AAAATGTCAA GGCCAGCTTA TGACCAGGAA GCTCTAGTGA 120
GAAGTTGCCC AGGGGGTCTA GGGGACAGGA GCGGGGTGGA GGGGACACAG ATGATTGCCT 180
GGAGCAATTT TTAATGTGCT GCCTCTAACT CACTGCTTGC CTTTTACTAC ACTCATCTGA 240
AAAGAAATGA GAAGTCTGGG CATGCCAGAG GCAAGAGGAA CCAGCTCACC ACTTCTCAAG 300
CCAGAATGGA AAAGATGGCA GAAGCATAGT TGTACAAGGA CCCCAGCATC AGTCAGACAG 360
AAGGAAACCT ATAATATTAT GCAATGAGAG ACCCTGAGGA TGTTCTTCAG ACAAACCCCA 420
GCAGGACCAA TCCAACTCCA AGCTTGAGCG TCCACTCCAA GCTTGAAGAT TAAACAATAA 480
GAAAAAATTC GGGTCCACAG GTGAAATACA CACTTTCTAA GCACAATGAG CAACTTTATA 540
GTAGATAGCT GGACAACCAA GTACACTAAC TGCAAGCATA AGAACAGTAT TCATGTTGTA 600
AATCGAGTAC CAACTACTAT TAGTTTTTTG TTGTTTTGCT TTTTGCAATA TTTCTTCTCA 660
TATTTTATTT TAAATCTAAG CTAATTTCTT TATAAGAACA GGCTAAGGCT TATTTTCTGT 720
GGCTGATCCA GCCTTACAAG AAAAAAGATT TCACTGTGTC CCTCAGAAAC CTACTCCTGT 780
CTACATCACA CTGTCGAGCT CTCTCTTTAT ACCCCATGTG ACAGATAAGA AAACAGAAGT 840
CCAGAGAGAG CAAGTGACTC ATCCAAGGTC AAACTTCTTG CTAACACATC TAGGACGAGA 900
ATAAGGGCTC AAGAAGCCCA CTATGGGTCT CTTGCCGTAT CACTGCTGCA AATGACCAGG 960
CATACTGGTG TCTTGAATAC AAAGTTTATT TGTAAAGGGG AAAAAAAAAA AGCCAACATG 1020
AGTCATCTGC ATTGTCAACG GGCTCCACAC AGGTTGTTCT AATAAAGCAT CCAGCACCTC 1080
CAGAACCACT TGTTTCTGAA AGCACCAACC TACGCAGACA CTAGCAGGCC ATGTCTTCCA 1140
CCCTTGCCAC CCTCGAGGCT GTGAGCAGAT GCGCTGTTGG GCTCTGGGGA TCTAGAGGTG 1200
TCACTTAAAG AGCAAGGGAG CCTGGAGCTT GGCAGTACTG ACTGGATGAG TGGATGGGTG 1260
GGTGTATGAG GACATGGGAG TGTTTTCTGA CAGCTCCCGG AGATAGTTAT GATATCATGC 1320
AGCCTAATCC CACTCATCTT GGAACACCCC AAACATCTCA TCCGCTCAGC TGTCCCTCCT 1380
CAACTTCCTC AGGGCAAAAG CACTGCAGTC TGAGGTGAAT CTGGCCGCTG GGGAGGGGCG 1440
GTAGTCGGCC CCAGCAGCAG AGGAAGCAAC GCTCAGCTCC CTCCTCCACC CACCCCGTAC 1500
AGGAACTCCC CACTGGGTCT TCAGATGCCA GAGGCGTACC CAGCTCGGAG CCTGCCCCGG 1560
GTCTCAGGGT CGGTCCCGAA AGAACGGGGG AGGAGGAAGG CTCTATCCCG CCCCCGCCTC 1620
ACCTCTACTC CCCGACCCCC AGGCGCCGAC CCTTCTCACC CGCAAGGTCC GCCGCCGGAC 1680
TCTTGTCCAC TCCCAGAGAC CCTGAGCGCA CCCCTTTCTC GGCGTCCTCA AAGGACCCGC 1740
GTTTCCCACC TTCCCATACG GGGCCCTCCC GGCCGCCCCG GCCCAAGCCC TTTGCACTGC 1800
GTCCCCCGGC CCCTGAGTCC GCCCCGCACC CGCACTTCCC GCCCGGCCCC GCGGGCTCGC 1860
GGTCCGCCCC AACTTTTCCC AGCCCCCGCC CCGCAGCAAC CGGGATGCAG CGTCTCGAGC 1920
CGCGACGGGC AGGCGAGCTC GAGTCCCTCG GGCCCCCAAC CCCGCCCGCA CGAGTTGCGC 1980
TCGGGACCCG CCGGGCGCCC AGGCCTGGGT CAGCAGCACT 2020
|
